The role of exposure history on HIV acquisition: insights from repeated low-dose challenge studies.
about
Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate ModelsPredicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.Comparisons of non-Gaussian statistical models in DNA methylation analysis.Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.Short communication: a repeated simian human immunodeficiency virus reverse transcriptase/herpes simplex virus type 2 cochallenge macaque model for the evaluation of microbicidesMultiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcomeRepeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.Complex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses.A discrete-time survival model with random effects for designing and analyzing repeated low-dose challenge experiments.Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaquesHost Responses to Pathogen Priming in a Natural Songbird Host.Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control.A method to address between-subject heterogeneity for identification of principal surrogate markers in repeated low-dose challenge HIV vaccine studies.Non-human primate models of hormonal contraception and HIV.Vaccine Effects on Heterogeneity in Susceptibility and Implications for Population Health Management.
P2860
Q27318212-1C4439E7-CFC3-422F-8E8A-197CB5394B1FQ33638320-586D4DDB-BCD7-4D6B-ABF1-81666EAC7693Q33907898-E576A4F5-D08E-4248-807E-747FAA85B3B3Q34399723-0A1D95C0-1052-4CB3-83E7-D7C740B19218Q34399737-FD5553F8-BE8F-4278-9C88-0CC14340AFB7Q34593105-24C96F1C-2876-49A0-B5A4-8ECD08AC86EEQ35861236-335517C1-5B90-4B4B-80F7-C6E029CF69E7Q36255281-F4AC1190-3032-4B27-B5CB-705F8DB8F908Q36674455-592C4F97-EED9-4B9B-A487-BB27C5A5F1ECQ37547763-935920E0-E5AE-469B-91E3-A62A0CF60BF6Q38648264-275BED7C-318F-47B8-A96F-6E4113F54AB4Q38982515-EFCF2E0C-8AE0-4B6C-BC27-DBD00715CB8EQ40101835-F529C12D-4B64-4955-9FBA-D569A81CF1CAQ42225882-EF11C8BF-4EE4-441F-BBF6-BEA335A7BDCCQ45073598-66F5C7F0-2BCA-4ABD-AE2F-D2C32FDA0061
P2860
The role of exposure history on HIV acquisition: insights from repeated low-dose challenge studies.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The role of exposure history o ...... ed low-dose challenge studies.
@ast
The role of exposure history o ...... ed low-dose challenge studies.
@en
The role of exposure history o ...... ed low-dose challenge studies.
@nl
type
label
The role of exposure history o ...... ed low-dose challenge studies.
@ast
The role of exposure history o ...... ed low-dose challenge studies.
@en
The role of exposure history o ...... ed low-dose challenge studies.
@nl
prefLabel
The role of exposure history o ...... ed low-dose challenge studies.
@ast
The role of exposure history o ...... ed low-dose challenge studies.
@en
The role of exposure history o ...... ed low-dose challenge studies.
@nl
P2860
P1476
The role of exposure history o ...... ed low-dose challenge studies.
@en
P2093
Roland R Regoes
P2860
P304
P356
10.1371/JOURNAL.PCBI.1002767
P577
2012-11-08T00:00:00Z